Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Short Interest Down 6.3% in November
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) saw a large decline in short interest in November. As of November 15th, there was short interest totalling 6,500,000 shares, a decline of 6.3% from the October 31st total of 6,940,000 shares. Based on an average daily trading volume, of 713,900 shares, the days-to-cover ratio is presently […]
More Stories
Alpha Financial Markets Consulting (LON:AFM) Shares Down 0.1% – Should You Sell?
Alpha Financial Markets Consulting plc (LON:AFM – Get Free Report)’s stock price was down 0.1% on Tuesday . The stock...
BW LPG (OTCMKTS:BWLLY) Shares Down 0.1% – Here’s What Happened
BW LPG Limited (OTCMKTS:BWLLY – Get Free Report) shares were down 0.1% on Tuesday . The stock traded as low...
Argan (NYSE:AGX) Issues Earnings Results
Argan (NYSE:AGX – Get Free Report) issued its earnings results on Thursday. The construction company reported $2.00 earnings per share...
HOCHTIEF Aktiengesellschaft (OTCMKTS:HOCFF) Shares Up 6.3% – Should You Buy?
HOCHTIEF Aktiengesellschaft (OTCMKTS:HOCFF – Get Free Report)’s stock price shot up 6.3% during trading on Tuesday . The stock traded...
Wajax (OTCMKTS:WJXFF) Trading Down 0.7% – Here’s Why
Wajax Co. (OTCMKTS:WJXFF – Get Free Report)’s share price dropped 0.7% during trading on Tuesday . The stock traded as...
Domo (NASDAQ:DOMO) Updates FY 2025 Earnings Guidance
Domo (NASDAQ:DOMO – Get Free Report) issued an update on its FY 2025 earnings guidance on Thursday morning. The company...